Washington University School of Medicine

Digital Commons@Becker
2020-Current year OA Pubs

Open Access Publications

3-16-2021

Postoperative complications are associated with long-term
changes in the gut microbiota following colorectal cancer surgery
Felix C F Schmitt
Heidelberg University Hospital

Martin Schneider
Heidelberg University Hospital

William Mathejczyk
Heidelberg University Hospital

Markus A Weigand
Heidelberg University Hospital

Jane C Figueiredo
Cedars-Sinai Medical Center

See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/oa_4
Part of the Medicine and Health Sciences Commons

Recommended Citation
Schmitt, Felix C F; Schneider, Martin; Mathejczyk, William; Weigand, Markus A; Figueiredo, Jane C; Li,
Christopher I; Shibata, David; Siegel, Erin M; Toriola, Adetunji T; Ulrich, Cornelia M; Ulrich, Alexis B; Boutin,
Sébastien; and Gigic, Biljana, "Postoperative complications are associated with long-term changes in the
gut microbiota following colorectal cancer surgery." Life (Basel). 11, 3. 246 (2021).
https://digitalcommons.wustl.edu/oa_4/418

This Open Access Publication is brought to you for free and open access by the Open Access Publications at
Digital Commons@Becker. It has been accepted for inclusion in 2020-Current year OA Pubs by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Authors
Felix C F Schmitt, Martin Schneider, William Mathejczyk, Markus A Weigand, Jane C Figueiredo,
Christopher I Li, David Shibata, Erin M Siegel, Adetunji T Toriola, Cornelia M Ulrich, Alexis B Ulrich,
Sébastien Boutin, and Biljana Gigic

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/oa_4/418

life
Article

Postoperative Complications Are Associated with Long-Term
Changes in the Gut Microbiota Following Colorectal
Cancer Surgery
Felix C. F. Schmitt 1, *, Martin Schneider 2 , William Mathejczyk 1 , Markus A. Weigand 1 , Jane C. Figueiredo 3 ,
Christopher I. Li 4 , David Shibata 5 , Erin M. Siegel 6 , Adetunji T. Toriola 7 , Cornelia M. Ulrich 8,9 ,
Alexis B. Ulrich 2,10 , Sébastien Boutin 11,12,† and Biljana Gigic 2,†
1

2

3

4

5




6

7

Citation: Schmitt, F.C.F.; Schneider,
M.; Mathejczyk, W.; Weigand, M.A.;

8

Figueiredo, J.C.; Li, C.I.; Shibata, D.;

9

Siegel, E.M.; Toriola, A.T.; Ulrich,

10

C.M.; et al. Postoperative

11

Complications Are Associated with
Long-Term Changes in the Gut

12

Microbiota Following Colorectal
Cancer Surgery. Life 2021, 11, 246.
https://doi.org/10.3390/life11030246
Academic Editor: Caterina Aurilio
Received: 11 February 2021
Accepted: 13 March 2021
Published: 16 March 2021

Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons

*
†

Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany;
William.Mathejczyk@gmx.de (W.M.); Markus.Weigand@med.uni-heidelberg.de (M.A.W.)
Department of General, Visceral and Transplant Surgery, Heidelberg University Hospital,
69120 Heidelberg, Germany; martin.schneider@med.uni-heidelberg.de (M.S.);
aulrich@lukasneuss.de (A.B.U.); Biljana.Gigic@med.uni-heidelberg.de (B.G.)
Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center,
Los Angeles, CA 90048, USA; jane.figueiredo@cshs.org
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA;
cili@fredhutch.org
Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38163, USA;
dshibata@uthsc.edu
Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA;
Erin.Siegel@moffitt.org
Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine and
Siteman Cancer Center, St Louis, MI 63110, USA; toriolaa@wudosis.wustl.edu
Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT 84112, USA; Neli.ulrich@hci.utah.edu
Department of Population Health Sciences, University of Utah, Salt Lake City, UT 84112, USA
Department of Surgery I, Lukas Hospital Neuss, 41460 Neuss, Germany
Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital,
69120 Heidelberg, Germany; Sebastien.Boutin@med.uni-heidelberg.de
Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL),
69120 Heidelberg, Germany
Correspondence: Felix.Schmitt@med.uni-heidelberg.de; Tel.: +49-6221-56-39421
These authors contributed equally to this work.

Abstract: Changes in the gut microbiome have already been associated with postoperative complications in major abdominal surgery. However, it is still unclear whether these changes are transient
or a long-lasting effect. Therefore, the aim of this prospective clinical pilot study was to examine
long-term changes in the gut microbiota and to correlate these changes with the clinical course
of the patient. Methods: In total, stool samples of 62 newly diagnosed colorectal cancer patients
undergoing primary tumor resection were analyzed by 16S-rDNA next-generation sequencing. Stool
samples were collected preoperatively in order to determine the gut microbiome at baseline as well
as at 6, 12, and 24 months thereafter to observe longitudinal changes. Postoperatively, the study
patients were separated into two groups—patients who suffered from postoperative complications
(n = 30) and those without complication (n = 32). Patients with postoperative complications showed
a significantly stronger reduction in the alpha diversity starting 6 months after operation, which does
not resolve, even after 24 months. The structure of the microbiome was also significantly altered from
baseline at six-month follow-up in patients with complications (p = 0.006). This was associated with
a long-lasting decrease of a large number of species in the gut microbiota indicating an impact in the
commensal microbiota and a long-lasting increase of Fusobacterium ulcerans. The microbial composition of the gut microbiome shows significant changes in patients with postoperative complications
up to 24 months after surgery.
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1. Introduction
Postoperative complications are still a relevant problem in the daily clinical practice.
Due to the continuous improvement in operation techniques and the high safety standards
in anesthesia and intensive care, severe perioperative complications have been reduced over
the last decades. The use of new diagnostic approaches such as next-generation sequencing
(NGS) gave us new insights in microbial processes that are highly complex [1–4]. Recent
studies have already shown that the composition of the patient’s microbiome has an impact
on the individual clinical outcome [5,6]. Especially the gut microbiota is in the focus
of postoperative complications following major abdominal surgery due to its influence
on host immune responses and the occurrence of infections [7,8]. Our working group
already discriminated separate microbial communities of the gut microbiome in patients
undergoing pancreatic surgery. Depending on the individual composition, patients showed
significant higher levels of c-reactive protein (CRP) and an increased leukocyte count,
as well as a more frequent incidence of postoperative complications, associated with a
prolonged hospital stay [9]. Due to the widespread use of broad-spectrum antibiotics
and the impact of the operative procedure itself, it is not surprising that the microbial
composition might be hampered [10–12]. However, it is still unclear whether these changes
are transient or a long-lasting effect. Thus, this prospective, observational study aimed
to examine changes in the gut microbiota as well as its impact on the clinical course after
colorectal cancer surgery. With particular interest, we focused on long-term changes in
this project because nearly all pre-existing NGS data were measured during the primary
hospital stay or within the first six months after surgery. However, patients’ long-term
outcome has not yet been evaluated in the focus of postoperative complications.
2. Methods
2.1. Study Design
The present project used stool samples and data from the German site of the multicentered international ColoCare Study (ClinicalTrials.gov identifier: NCT02328677), approved by the Ethics Committee of the Medical Faculty at the University of Heidelberg,
Germany (Ethical Code: S-134/2016). The following inclusion criteria were applied: patients with a newly diagnosed primary invasive colorectal cancer, from the age of 18 years.
Patients were enrolled prior to surgery at the Heidelberg University Hospital, Germany,
between April 2016 and June 2018. Stool samples were collected before the operation as
well as 6, 12, and 24 months afterwards. A total of 62 patients met the criteria and were
included into analyses.
Preoperative stool samples were used to determine the baseline microbiota without
operative or pharmacological influence factors, and postoperative samples allowed the
evaluation of longitudinal changes in the microbiota. Thirty minutes before the surgical
procedure, each patient received a standardized single shot of 1 g sulbactam and 2 g
ampicillin. Postoperatively, the study patients were separated into two groups consisting
of those who suffered postoperative complications and those who had a noncomplicated
clinical course according to the Clavien–Dindo classification. Further, all patients were
re-evaluated for survival 24 months after the surgery.
2.2. Collection and Storage of Stool Samples
Stool samples were collected at baseline and at 6-, 12-, and 24-month follow-up time
points. Participants collected and froze stool specimen at home. Samples were brought
in during a visit or sent to the lab with provided freeze packs. The stool samples were
stored at −80 ◦ C until further processing. Deoxyribonucleic acid (DNA) was extracted
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from 200 mg plain stool samples using the PSP® Spin Stool DNA Kit (Stratec, Birkenfeld,
Germany) according to the manufacturer’s protocol.
2.3. Microbiota Analysis
16S-rDNA libraries were prepared by amplifying the V4 region as previously published and sequenced in an Illumina Miseq instrument (2 × 300 bp) [5,9]. R package dada2
was used to process raw sequences as following: filtration and trim with the following parameters: maximum ambiguity: 0, number of expected errors for each read: 1, and truncate
reads at the first instance of a quality score less than 2. Curated reads were as assemble
as contigs and checked for chimera with the default parameters. Ribosomal sequence
variants (RSV) were then assigned to taxonomy using the Silva database (version 132). In
order to analyze only true biological signal, RSV associated with eukaryotes, archaea, and
chloroplasts or detected either in the negative control of the extraction or in the PCR were
removed from the analysis. The RSV table was used to calculate descriptive indices for
alpha diversity (Shannon index), richness (number of RSV observed), and dominance (relative abundance of the most dominant RSV). A total of 2,627,130 reads in total were used,
with a mean number of 15,012 reads per sample. Rarefaction curves for all the samples
were evaluated to check if a plateau was reached. Beta diversity measures were performed
to examine the differences between the samples based on weighted Unifrac distances.
2.4. Diatery Patterns
Dietary behavior within this study was assessed using food frequency questionnaires
and has been described previously by Ulrich et al. and Gigic et al. [13,14]. Patients with
high scores for a dietary pattern have a greater tendency to follow the pattern compared
with patients with a low score. Labeling of the factor was performed quantitatively using
a cut-off of 0.40 of the factor loadings. The dietary pattern data were categorized into
approximate appropriate tertiles.
2.5. Statistical Analysis
PERMANOVA was performed to analyze the differences in the structure of the microbiota between the groups. Diversity index association with clinical parameters (time, body
mass index (BMI), therapy, and disease severity) was performed with a linear mixed-effect
model with patient ID as a random effect to consider inter-individual variation, while intergroups comparison was performed with a Mann–Whitney U test. To compare temporal
microbial changes at the RSV levels, we used Deseq2 including patient ID as a co-variable.
All statistical analyses were performed with R 3.4.4 and the packages Deseq2, microbiome,
and phyloseq.
3. Results
3.1. Cohort Demographics and Clinical Differences
In total, 62 patients undergoing colorectal cancer surgery were included (Table 1).
Thirty-five patients underwent rectum resection and 27 underwent a partial excision of the
colon. Postoperatively, patients were classified into two groups consisting of those who
suffered from postoperative complications (n = 30) and those who had a noncomplicated
clinical course (n = 32). Fifty-eight patients survived the 24-month observation period.
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Table 1. Patients’ characteristics.
Patients’ Characteristics
64 (54.3–72.8)

Age (years)
Gender
Female

34 (54.8%)

Male

28 (45.2%)

Body Mass Index

26.4 (24.3–30.0)
Site of Surgery

Colon

27 (58.7%)

Rectum

35 (41.3%)
Chemotherapy

Neo–Adjuvant

15 (24.2%)

Adjuvant

19 (30.6%)
Tumor Staging

Carcinoma In Situ

1 (1.6%)

Grade I

12 (19.4%)

Grade II

18 (29.0%)

Grade III

17 (27.4%)

Grade IV

14 (22.6%)

Complications (Number of Patients; Double Naming Feasible)
Surgical

22 (35.5%)

Medical

20 (32.3%)

Both

14 (22.6%)

Complication Grade (According to the Clavien–Dindo Classification)
Grade I

10 (16.1%)

Grade II

11 (17.7%)

Grade III

7 (11.3%)

Grade IV

2 (3.2%)

Survivor (After 24-months)

58 (93.5%)

Data are presented by median and interquartile range (Q1–Q3) or quantity and percentage.

3.2. Associations between Complication and the Microbiota Structure
Patients with a postoperative complication showed no significant differences in alpha
diversity compared to patients without complications at baseline (Figure 1). Overall, we
observed a decrease of the Shannon index in both groups after operation; however, the
change was only statistically significant in the group of patients with a postoperative
complication. After operation, the richness decreased significantly in both groups in a
long-term manner, with a significant decrease still visible after 24 months. In the group
with complication, dominance was significantly increased at 6 months and 12 months and
evenness was decreased after operation at 6 months.

Life
Life 2021,
2021, 11,
11, 246
x FOR PEER REVIEW

55 of
10
of 11

Figure 1.
1. Patients
Patients with postoperative complications
Figure
complications show
showaastronger
strongerreduction
reductionininthe
thealpha
alphadiversity,
diversity,
which
does
not
resolve
even
after
24
months.
Following
symbols
were
used
to
represent
signifiwhich does not resolve even after 24 months. Following symbols were used to represent significance:
cance:
p <was
0.05indicated
was indicated
* p <by
0.01
by **p and
p < 0.001
p < 0.05
by * p by
< 0.01
** and
< 0.001
by ***.by ***.

The
The overall
overall structure
structure of the microbiota was unaffected after the operation in patients
inin
their
microbiota
without complications,
complications, while
whilepatients
patientswith
withcomplications
complicationsshowed
showeda shift
a shift
their
microbiat 6atmonths
compared
to baseline
(PERMANOVA:
R2R²
= =0.09,
ota
6 months
compared
to baseline
(PERMANOVA:
0.09,p-value
p-value==0.006).
0.006). After 12
and 24 months,
months, no significant difference to the baseline was observed, indicating a good
and
resilience overall (Figure S1). At
At baseline,
baseline, patients in the complicated group had a higher
resilience
abundance of
of specific
specific taxa,
taxa, especially
especially species
species such
such as Akkermansia
Akkermansia muciniphila,
muciniphila, ButyriciButyriciabundance
monas
sp.,
and
Prevotella
sp.,
and
from
the
families
Ruminococcaceae
and
Muribaculaceae
monas sp.,
(Table S1).
In patients
patients with a postoperative
complication, we observed a significant
In
postoperative complication,
significant change
change in
in
the abundance
abundance of
of aa large
large number
number of
of RSVs
RSVs at
at 66 months
(Figure 2).
Most of
of the
the RSVs
RSVs were
the
months (Figure
2). Most
were
decreased in
in their
their abundance
abundance after
after the
the operation,
operation, indicating
indicating aa large
large detrimental
detrimental impact
impact on
on
decreased
the
commensal’s
population.
The
majority
of
those
RSVs
remained
significantly
decreased
the commensal’s population. The majority of those RSVs remained significantly decreased
at 12
12and
and24
24months,
months,indicating
indicating
a long-lasting
effect.
the other
few species
at
a long-lasting
effect.
On On
the other
side,side,
a fewaspecies
were
were
increased
in
abundance
6
months
after
the
operation,
but
all
of
them
to
increased in abundance 6 months after the operation, but all of them resolved resolved
to the basethe
baseline
abundance
except
Fusobacterium
ulcerans,
which
still
showed
a
long-lasting
line abundance except Fusobacterium ulcerans, which still showed a long-lasting increase
increase
after 24(Figure
months2).
(Figure 2).
after
24 months

5

Life
FOR PEER REVIEW
Life2021,
2021,11,
11,x246

66of
of11
10

Figure 2. Heatmap representing the longitudinal changes in the group of patients with postoperative complications.
Figure 2. Heatmap representing the longitudinal changes in the group of patients with
Only significantly differentially abundant ribosomal sequence variants (RSVs) (p-value < 0.05 and log2 (fold change) > 1)
postoperative complications. Only significantly differentially abundant ribosomal sequence
compared to the baseline are displayed (Deseq2). Several taxonomical levels were analyzed: (A) RSV, (B) genus, (C) order,
variants (RSVs) (p-value < 0.05 and log2 (fold change) > 1) compared to the baseline are
and (D) phylum. Taxa enriched in the baseline are displayed in blue, and taxa enriched after complication are in red. The
displayed (Deseq2). Several taxonomical levels were analyzed: (A) RSV, (B) genus, (C) order,
color intensity is relative to the log2 fold change, and nonsignificant taxa are displayed in white.
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p-value = 0.7937). Complicated group: Shannon index (western: p-value = 0.8432; bread
and butter: p-value = 0.6027; fruit and vegetable: p-value = 0.1904), dominance (western:
p-value = 0.8711; bread and butter: p-value = 0.5274; fruit and vegetable: p-value = 0.5606),
richness (western: p-value = 0.837; bread and butter: p-value = 0.4988; fruit and vegetable: p-value = 0.232), and Pielou index (western: p-value = 0.7867; bread and butter:
p-value = 0.3243; fruit and vegetable: p-value = 0.3746).
The BMI in the complicated and in noncomplicated group showed no significant
difference. Furthermore, we have not detected any impact on the diversity of the microbiome; only the richness in the complicated group was marginally affected (Shannon index:
p-value = 0.0813, dominance: p-value = 0.2798; richness: p-value = 0.0247; Pielou index:
p-value = 0.2956).
3.4. Tumor Stage and Chemotherapy
We did not observe any impact of chemotherapy prior or after surgery on the microbiome structure or diversity. Furthermore, we evaluated the impact of an advanced tumor
disease on the microbiome. Therefore, we compared patients with and without metastasis,
but microbial structure was not affected.
4. Discussion
The composition of the gut microbiome has been associated with the clinical course
of patients, following major abdominal surgery. Due to the surgical stress and the use
of broad-spectrum antibiotics, a reduction in alpha diversity and richness would not be
surprising, especially in the early postoperative period. However, the long-term effects of
such changes are still uncertain. Therefore, the present study aimed to examine long-term
changes in the gut microbiota and the potential influence on postoperative complications
in patients undergoing colorectal surgery.
Prior to surgery, we did not observe any significant differences in alpha diversity,
richness, dominance, and evenness, between the patient groups with and without postoperative complications. This indicates an intact microbiota prior to the surgical procedure
in both groups. Patients with a noncomplicated clinical course showed no changes in
their microbial structure in the postoperative period, whereas patients in the complicated
group revealed a shift until the six-month follow-up and a recovery until 12 months after
surgery. Both groups showed a significant decrease in richness over the whole 24 months
after surgery, with a more pronounced effect in the complicated group. The overall alpha
diversity was significantly affected only in the complicated group and did not resolve after
24 months. The decrease in bacterial diversity and richness, together with a flare-up of
problematic bacteria like Pseudomonas aeruginosa is an already described effect that can
also be observed in critically ill patients [5,15]. However, apart from the changes in the
microbial community, the long-lasting timespan in which this effect is detectable is quite
surprising, because trials with shorter follow-ups indicated a faster recovery of the gut
microbiota [16]. The reason for this might be that all patients in our cohort received major
abdominal surgery with a partial excision of the bowel. Furthermore, the majority of our
patients received an additional chemotherapy. Both could be reasons for a longer lasting
imbalance of the gut microbiota.
Previous studies in critically ill intensive care unit (ICU) patients have suggested that
also a severe dysbiosis is seen in patients with a complicated course [17–19]. We cannot
confirm these findings, as well as other studies with perioperative patients [9]. Instead
of the described severe dysbiosis, more subtle variations seem to be important in the
perioperative cohorts, which is probably due to less severe complications and shorter need
for antibiotic treatment.
Anti-infective treatments (e.g., antibiotics) are able to aggravate microbial impairment,
paving the way for further surgical site infections like Carbapenem-resistant Pseudomonas
aeruginosa. Recent data indicate that also the selection of the antibiotic itself has an impact
on the individual microbial composition. It was shown that in ICU patients, piperacillin–
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tazobactam was associated with a lower abundance of potentially protective taxa and an
increased risk of Enterococcus domination [15]. We were not able to show any effects of a
specific antibiotic on the gut microbiota. However, our results may support the assumption
that the prolonged use of antibiotics due to a complication might accelerate an overgrowth
of problematic species and may remove commensals that compete with these taxa. Patients
in the group with postoperative complications showed a large spectrum of species that
were significantly reduced compared to baseline. While the consortium of commensals
tends to resolve after 24 months, we observed a significant loss in the abundance in several
taxa, as shown in Figure 2. Potentially protective taxa like Faecalibacterium and Blautia
were significantly decreased after surgery. Faecalibacterium species have been evaluated in
probiotics in order to prevent a microbial imbalance in the gut [20,21], whereas Blautia has
been identified as protective in case of a significant decrease in bacterial diversity together
with a flare-up of problematic bacteria such as Clostridium difficile [22]. Furthermore, not
only a loss of so-called protective taxa, but also a long-lasting increase of Fusobacterium
ulcerans has been shown. Fusobacterium ulcerans is a newer species, isolated from tropical
ulcers, and resembles most closely the gastrointestinal species Fusobacterium varium [23,24].
It belongs to a group of fusobacteria that are generally more resistant to antimicrobial agents
compared with the oral strains [25]. This might indicate a selection pressure in the gut
microbiota under the prolonged antibiotic therapy in the complicated group.
Interestingly, at baseline, the composition of the gut microbiota showed a higher
abundance of specific taxa like Akkermansia in the complicated group. Researchers assume
that a specific “pathobiome”, which is not necessarily associated with a fulminant dysbiosis,
might be responsible for increased postoperative complications [26,27]. This is in line with
our previous findings. We already showed in patients undergoing pancreatic surgery that
specific compositions of the gut microbiota, when they appear before surgery, characterized
by a higher amount of Akkermansia are more prone to complications [9]. Furthermore, the
same effect has recently been detected in patients with gastric cancer who underwent a
radical distal gastrectomy [28]. There are two potential explanations for the increased
abundance of Akkermansia. The mucin layer that protects the epithelial cells in the gut is
degraded by Akkermansia, and this could make the physiological barrier more vulnerable
against pathogen invasion [29–31]. This might also be the reason for the significant and
impressively long-lasting decrease in alpha diversity within the group with postoperative complications. On the other hand, the pro-inflammatory potential of Akkermansia
is very weak, and its presence seems to have a protective effect on the epithelium, as
shown in vitro [32]. Akkermansia muciniphilia, in particular, strengthens the integrity of the
enterocyte monolayer and is therefore likely to help protect a previously damaged bowel
barrier [32,33]. Thus, a shift in the gut microbiome with an upregulation of some taxa
might be another physiological function of the immune system to protect itself against
pathogens [34].
There are several limitations that need to be addressed. The study was conducted in a
single center and included only patients undergoing colorectal cancer surgery. Moreover,
we evaluated only a relatively small patient cohort, and some confounders cannot be fully
ruled out, which could potentially influence or complicate the correlation of the clinical
complication rates and the changes in the gut microbiome; for example, the heterogeneous
types of complications, the different types of operations, and the individual antibiotic treatments (e.g., type of antibiotic and length of therapy) in case of a postoperative complication.
Furthermore, the majority of patients in the complicated group suffered only from minor
complications that required, in most cases, only an antibiotic treatment. Nevertheless, we
have performed several statistic tests to evaluate the impact of potential disruptive factors,
for example, the use of chemotherapeutic agents, to ensure a reliable dataset.
5. Conclusions
To our knowledge, this the first study in colorectal cancer surgery that shows an association between long-term changes in the gut microbiota and postoperative complications.
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The microbial composition in patients with complication after colorectal surgery revealed
significant structural differences and a long-lasting decrease in a large number of species,
and indicates an impact in the commensal microbiota up to two years after surgery.
Supplementary Materials: The following are available online at https://www.mdpi.com/2075-172
9/11/3/246/s1: Figure S1: Microbial composition visualized by principal coordinate analysis (PCoA);
Table S1: Differentially abundant RSV at baseline between patient with complication and patient
without complication; Table S2: Food group factor loadings for the “western”, “fruit & vegetable”
and “bread & butter” dietary pattern, identified using PCA.
Author Contributions: M.S., A.B.U., F.C.F.S., C.M.U., S.B., and B.G. conceived of the study and
participated in its design; F.C.F.S., M.S., W.M., J.C.F., C.I.L., D.S., E.M.S., A.T.T., and S.B. analyzed
and acquired study data; M.A.W., C.M.U., A.B.U., S.B., and B.G. participated substantially in the
coordination and organization of the study; F.C.F.S., B.G., and S.B. prepared the tables and figures and
wrote the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding: The authors received no external funding.
Institutional Review Board Statement: The Study has been approved by the local Ethics Committee
(Ethics Committee of the Medical Faculty at the University of Heidelberg; Ethical Code: S-134/2016;
ClinicalTrials.gov identifier: NCT02328677). All study patients signed written informed consent.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: The detailed datasets are available in figshare: 10.6084/m9.figshare.14215760.
Acknowledgments: The authors thank U. Krauser, J. Pfister, and S. Hassel for their excellent technical
assistance. Moreover, we thank Torsten Koelsch for patient recruitment and follow-up and for sample
collection within the ColoCare Study. We thank the laboratory of M. Schneider for sample processing
and storage.
Conflicts of Interest: The authors declare that the research was conducted in the absence of any
commercial or financial relationships that could be construed as a potential conflict of interest.

References
1.
2.
3.
4.
5.

6.

7.
8.

9.

10.
11.
12.

Codner, P.A.; Herron, T.J. The shifting microbiome in surgical stress. Curr. Surg. Rep. 2017, 9, 4–5. [CrossRef]
Kamada, N.; Seo, S.-U.; Chen, G.Y.; Núñez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev.
Immunol. 2013, 13, 321–335. [CrossRef] [PubMed]
Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444,
1022–1023. [CrossRef] [PubMed]
Marteau, P.; Lepage, P.; Mangin, I.; Suau, A.; Dore, J.; Pochart, P.; Seksik, P. Review article: Gut flora and inflammatory bowel
disease. Aliment Pharmacol. Ther. 2004, 20, 18–23. [CrossRef] [PubMed]
Schmitt, F.; Lipinski, A.; Hofer, S.; Uhle, F.; Nusshag, C.; Hackert, T.; Dalpke, A.; Weigand, M.; Brenner, T.; Boutin, S. Pulmonary
microbiome patterns correlate with the course of disease in patients with sepsis-induced ARDS following major abdominal
surgery. J. Hosp. Infect. 2020, 105, 438–446. [CrossRef]
Bartolini, I.; Risaliti, M.; Ringressi, M.N.; Melli, F.; Nannini, G.; Amedei, A.; Muiesan, P.; Taddei, A. Role of gut microbiotaimmunity axis in patients undergoing surgery for colorectal cancer: Focus on short and long-term outcomes. World, J. Gastroenterol.
2020, 26, 2498–2513. [CrossRef]
Koliarakis, I.; Athanasakis, E.; Sgantzos, M.; Mariolis-Sapsakos, T.; Xynos, E.; Chrysos, E.; Souglakos, J.; Tsiaoussis, J. Intestinal
Microbiota in Colorectal Cancer Surgery. Cancers 2020, 12, 3011. [CrossRef]
Lankelma, J.M.; Van Vught, L.A.; Belzer, C.; Schultz, M.J.; Van Der Poll, T.; De Vos, W.M.; Wiersinga, W.J. Critically ill patients
demonstrate large interpersonal variation in intestinal microbiota dysregulation: A pilot study. Intensiv. Care Med. 2017, 43, 59–68.
[CrossRef]
Schmitt, F.C.F.; Brenner, T.; Uhle, F.; Loesch, S.; Hackert, T.; Ulrich, A.; Hofer, S.; Dalpke, A.H.; Weigand, M.A.; Boutin, S. Gut
microbiome patterns correlate with higher postoperative complication rates after pancreatic surgery. BMC Microbiol. 2019, 19,
1–13. [CrossRef]
Pamer, E.G. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 2016, 352, 535–538. [CrossRef]
Blaser, M.J. Antibiotic use and its consequences for the normal microbiome. Science 2016, 352, 544–545. [CrossRef] [PubMed]
Ianiro, G.; Tilg, H.; Gasbarrini, A. Antibiotics as deep modulators of gut microbiota: Between good and evil. Gut 2016, 65,
1906–1915. [CrossRef]

Life 2021, 11, 246

13.

14.
15.

16.

17.
18.

19.

20.

21.
22.

23.
24.
25.
26.
27.
28.
29.
30.
31.
32.

33.

34.

10 of 10

Ulrich, C.M.; Gigic, B.; Böhm, J.; Ose, J.; Viskochil, R.; Schneider, M.; Colditz, G.A.; Figueiredo, J.C.; Grady, W.M.; Li, C.I.; et al.
The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes. Cancer Epidemiol. Biomark. Prev.
2019, 28, 591–601. [CrossRef] [PubMed]
Gigic, B.; Boeing, H.; Toth, R.; Böhm, J.; Habermann, N.; Scherer, D. Associations Between Dietary Patterns and Longitudinal
Quality of Life Changes in Colorectal Cancer Pa-tients: The ColoCare Study. Nutr. Cancer 2018, 70, 51–60. [CrossRef] [PubMed]
Pettigrew, M.M.; Gent, J.F.; Kong, Y.; Halpin, A.L.; Pineles, L.; Harris, A.D.; Johnson, J.K. Gastrointestinal Microbiota Disruption
and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Clin. Infect. Dis.
2019, 69, 604–613. [CrossRef] [PubMed]
Aardema, H.; Lisotto, P.; Kurilshikov, A.; Diepeveen, J.R.J.; Friedrich, A.W.; Sinha, B.; De Smet, A.M.G.A.; Harmsen, H.J.M.
Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study. Front. Cell. Infect.
Microbiol. 2020, 9, 467. [CrossRef]
McDonald, D.; Ackermann, G.; Khailova, L.; Baird, C.; Heyland, D.; Kozar, R.; Lemieux, M.; Derenski, K.; King, J.; Vis-Kampen,
C.; et al. Extreme Dysbiosis of the Microbiome in Critical Illness. mSphere 2016, 1. [CrossRef]
Ojima, M.; Motooka, D.; Shimizu, K.; Gotoh, K.; Shintani, A.; Yoshiya, K.; Nakamura, S.; Ogura, H.; Iida, T.; Shimazu, T.
Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients.
Dig. Dis. Sci. 2016, 61, 1628–1634. [CrossRef]
Zaborin, A.; Smith, D.; Garfield, K.; Quensen, J.; Shakhsheer, B.; Kade, M. Membership and behavior of ultra-low-diversity
pathogen communities present in the gut of humans during pro-longed critical illness. mBio 2014, 5, e01361-14. [CrossRef]
[PubMed]
Brahe, L.K.; Le Chatelier, E.; Prifti, E.; Pons, N.; Kennedy, S.; Blaedel, T.; Håkansson, J.; Dalsgaard, T.K.; Hansen, T.; Pedersen, O.;
et al. Dietary modulation of the gut microbiota—A randomised controlled trial in obese postmenopausal women. Br. J. Nutr.
2015, 114, 406–417. [CrossRef]
Matsumoto, T.; Ishikawa, H.; Tateda, K.; Yaeshima, T.; Ishibashi, N.; Yamaguchi, K. Oral administration of Bifidobacterium
longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J. Appl. Microbiol. 2008, 104, 672–680. [CrossRef]
Buffie, C.G.; Bucci, V.; Stein, R.R.; McKenney, P.T.; Ling, L.; Gobourne, A.; No, D.; Liu, H.; Kinnebrew, M.; Viale, A.; et al. Precision
microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nat. Cell Biol. 2015, 517, 205–208.
[CrossRef]
Adriaans, B.; Shah, H. Fusobacterium ulcerans sp. nov. from Tropical Ulcers. Int. J. Syst. Bacteriol. 1988, 38, 447–448. [CrossRef]
Claros, M.C.; Papke, Y.; Kleinkauf, N.; Adler, D.; Citron, D.M.; Hunt-Gerardo, S. Characteristics of Fusobacterium ulcerans, a new
and unusual species compared with Fusobacterium varium and Fusobacterium mortiferum. Anaerobe 1999, 5, 137–140. [CrossRef]
Citron, D.M. Update on the Taxonomy and Clinical Aspects of the GenusFusobacterium. Clin. Infect. Dis. 2002, 35, S22–S27.
[CrossRef] [PubMed]
Miniet, A.A.; Grunwell, J.R.; Coopersmith, C.M. The microbiome and the immune system in critical illness. Curr. Opin. Crit. Care
2021, 27, 157–163. [CrossRef] [PubMed]
Krezalek, M.A.; DeFazio, J.; Zaborina, O.; Zaborin, A.; Alverdy, J.C. The Shift of an Intestinal “Microbiome” to a “Pathobiome”
Governs the Course and Outcome of Sepsis Following Surgical Injury. Shock 2016, 45, 475–482. [CrossRef]
Liang, W.; Yang, Y.; Wang, H.; Wang, H.; Yu, X.; Lu, Y.; Shen, S.; Teng, L. Gut microbiota shifts in patients with gastric cancer in
perioperative period. Medicine 2019, 98, e16626. [CrossRef]
Van Passel, M.W.; Kant, R.; Zoetendal, E.G.; Plugge, C.M.; Derrien, M.; Malfatti, S.A. The genome of Akkermansia muciniphila, a
dedicated intestinal mucin degrader, and its use in exploring intes-tinal metagenomes. PLoS ONE 2011, 6, e16876.
Borchers, M.T.; Carty, M.P.; Leikauf, G.D. Regulation of human airway mucins by acrolein and inflammatory mediators. Am. J.
Physiol. Content 1999, 276, L549–L555. [CrossRef]
Moal, V.L.-L.; Servin, A.L. Anti-Infective Activities of Lactobacillus Strains in the Human Intestinal Microbiota: From Probiotics
to Gastrointestinal Anti-Infectious Biotherapeutic Agents. Clin. Microbiol. Rev. 2014, 27, 167–199. [CrossRef] [PubMed]
Derrien, M.; Van Baarlen, P.; Hooiveld, G.; Norin, E.; Müller, M.; De Vos, W.M. Modulation of Mucosal Immune Response,
Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front. Microbiol. 2011, 2, 166.
[CrossRef] [PubMed]
Reunanen, J.; Kainulainen, V.; Huuskonen, L.; Ottman, N.; Belzer, C.; Huhtinen, H.; De Vos, W.M.; Satokari, R. Akkermansia
muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl. Environ. Microbiol. 2015, 81,
3655–3662. [CrossRef] [PubMed]
Blander, J.M.; Longman, R.S.; Iliev, I.D.; Sonnenberg, G.F.; Artis, D. Regulation of inflammation by microbiota interactions with
the host. Nat. Immunol. 2017, 18, 851–860. [CrossRef] [PubMed]

